Article Text

Download PDFPDF
Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis
  1. Kuo Jiang,
  2. Yunshan Guo,
  3. Lin Xiao,
  4. Wenjie Pan,
  5. Jianbing Ma
  1. Department of Orthopaedic Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
  1. Correspondence to Professor Jianbing Ma, Department of Orthopaedic Surgery, Honghui Hospital, Xi’an Jiaotong University, No.555 East Youyi Road, Xi’an, Shaanxi Province 710054, China; 13299028888{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest the article by Boutet et al 1 aiming to determine the effect of interleukin (IL)-38 overexpression in the joints of arthritic mice and in human macrophages. This prospective study showed for the first time that IL-38 overexpression attenuates the severity of experimental arthritis. The authors reported that IL-38 may exert its anti-inflammatory effects by decreasing the production of proinflammatory cytokines by macrophages and synovial fibroblasts. We really appreciate the work conducted by the authors and their findings support the use of IL-38 administration as a novel treatment strategy in arthritis. However, there are still some unresolved issues and unexplored aspects which need to be addressed.

First, is ionised calcium-binding adapter molecule 1 (Iba1) an appropriate marker for …

View Full Text


  • Contributors KJ was responsible for the concept and writing of the paper. YG and LX contributed to the concept. WP contributed to the concept and did the revising along with JM.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles